GlobalData’s Revati Tatake discussed key trends in biopharma which are set to have an impact in 2025 and beyond.
Lundbeck has received the US FDA fast track designation for amlenetug, a potential treatment for multiple system atrophy (MSA ...
The US Food and Drug Administration (FDA) has approved SpringWorks Therapeutics’ Gomekli (mirdametinib) to treat ...
EC has granted marketing authorisation to BridgeBio Pharma’s acoramidis under the Beyonttra brand name for treating ATTR-CM.
Travere’s stock price climbed by 14% following the announcement it will seek an FDA label expansion for Filspari.
Health Canada has approved MSD’s anti-programmed cell death protein 1 (PD-1) therapy Keytruda for treating adults with ...
The UK announced the funding at the AI Action Summit in Paris where it abstained from signing a declaration on an inclusive ...
Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...
Bio-Thera Solutions has signed an exclusive licence and commercialisation agreement with Intas Pharmaceuticals for BAT2506 in ...
The World Health Organization and St Jude Children's Research Hospital have kicked off a programme to distribute cancer ...
Given the number of comorbidities associated with obesity, the market's growth will impact the entire cardiometabolic disease ...
Grace has announced the initial closing of a financing round, securing almost $15m, for funding pre-commercial development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results